Psyence Biomedical Ltd. Gains 54.48%
Thu, Jul 25, 2024 at 07:09 PM
Psyence Biomedical Ltd. (PBM:NASDAQ) shot up at $0.6, representing a gain of 54.5%. On Thu, Jul 25, 2024, PBM:NASDAQ touched a New 2-Week High of $0.6. The stock appeared on our News Catalysts scanner on Wed, Jul 24, 2024 at 06:13 PM in the 'BIOTECH' category. From Thu, Jul 11, 2024, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Thu, Jul 25, 2024 at $1.17 with a volume of 81M+.
About Psyence Biomedical Ltd. (PBM:NASDAQ)
Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa.
Top 10 Gainers:
- Unico American Corporation (UNAM:NASDAQ), 150%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 100%
- The Container Store Group, Inc. (TCS:NYSE), 85.87%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 76.92%
- Predictive Oncology Inc. (POAI:NASDAQ), 74.77%
- Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ), 63.55%
- Nvni Group Limited (NVNI:NASDAQ), 56.2%
- Arrowroot Acquisition Corp. (ARRW:NASDAQ), 54.64%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 54.48%